BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Southwest Oncology Group 

1100 Fairview Ave N, MP-557
PO Box 19204
Seattle  Washington  98109-1024  U.S.A.
Phone: 206-667-4623 Fax: 206-667-4408


SEARCH JOBS




Industry
Medical Device






 Company News
Why Are African-Americans Less Likely To Survive Certain Cancers?, Southwest Oncology Group Study 7/8/2009 7:41:08 AM
Southwest Oncology Group Phase III Newly Diagnosed Multiple Myeloma Trial (S0232) Closed and Patients Given Choice to Switch to REVLIMID(R) Plus Dexamethasone 5/16/2007 11:06:06 AM
Oxford BioMedica PLC (OXB.L) Release: Southwest Oncology Group To Start A Phase II Trail Of Trovax In Breast Cancer 9/7/2006 2:42:36 PM
CuraGen Corporation (CRGN) And TopoTarget A/S Announce Southwest Oncology Group Opens New Lymphoma Trial With PXD101 8/24/2006 9:37:57 AM
Cancer and Leukemia Group B And Southwest Oncology Group To Evaluate The Addition Of Erbitux To Chemotherapy Or Chemotherapy And Avastin In First-Line Metastatic Colorectal Cancer10/19/2005 5:12:55 PM
Southwest Oncology Group's Prostate Cancer Study Featured In The New England Journal of Medicine10/19/2005 5:11:46 PM
Southwest Oncology Group Trial Shows That Taxotere(R) Significantly Improves Survival In Men With Prostate Cancer10/19/2005 5:11:40 PM
Southwest Oncology Group Initiates Phase 2 Clinical Trial Using Introgen Therapeutics, Inc.'s (INGN) Advexin Cancer Therapy10/19/2005 5:10:59 PM
Southwest Oncology Group Release: Study Findings Show The Longest Reported Survival Rate For Patients With Locally Advanced Lung Cancer10/19/2005 5:10:05 PM
Introgen Therapeutics, Inc.'s (INGN) Advexin Therapy To Be Combined With Surgery In Phase II Trial; Introgen And Southwest Oncology Group Enter Agreement For Clinical Testing10/19/2005 5:09:17 PM